Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease
- PMID: 30023307
- PMCID: PMC6047216
- DOI: 10.1016/j.ymgmr.2018.05.001
Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease
Figures

References
-
- Maetzel D., Sarkar S., Wang H., Abi-Mosleh L., Xu P., Cheng A.W., Gao Q., Mitalipova M., Jaenisch R. Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from niemann-pick type C patient-specific iPS cells. Stem Cell Rep. 2014;2:866–880. - PMC - PubMed
-
- Parra J., Klein A.D., Castro J., Morales M.G., Mosqueira M., Valencia I., Cortés V., Rigotti A., Zanlungo S. Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology. Biochem. Biophys. Res. Commun. 2011;413:400–406. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources